Literature DB >> 34006351

Secondary hypertriglyceridemia.

Clara Viñals1, Daniel Zambón2, Gema Yago1, Mònica Domenech3, Emilio Ortega4.   

Abstract

Secondary hypertriglyceridemia (HTG) are the most common cause of excess triglyceride rich particles in plasma. Faced with HTG, the first thing to do is rule out if there is a secondary cause since it can interact with genetic susceptibility and further aggravate the HTG. The most common causes are diet with high fat and high glycemic index, obesity, diabetes mellitus, alcohol consumption, renal disease like nephrotic syndrome, hepatic disorders and medications. The most important medications that can influence in HTG are oestrogen, isotretinoin, immunosuppressant therapy, L-asparaginase and with less effect thiazides, beta blockers, atypical antipsychotics and glucocorticoids. Other causes less frequent are endocrinological diseases such as Cushing's syndrome, acromegaly, hypothyroidism; pregnancy, lipodystrophies and autoimmune diseases. Lastly, the identifications and treatment or correction of secondary causes is a corner stone in the treatment of this disease.
Copyright © 2021 Sociedad Española de Arteriosclerosis. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Hipertrigliceridemia secundaria; Lipoproteínas de muy baja densidad; Metabolic syndrome; Secondary hypertriglyceridemia; Síndrome metabólico; Very low-density lipoprotein

Mesh:

Substances:

Year:  2021        PMID: 34006351     DOI: 10.1016/j.arteri.2021.02.006

Source DB:  PubMed          Journal:  Clin Investig Arterioscler        ISSN: 0214-9168


  2 in total

1.  Polygenic Risk of Hypertriglyceridemia Is Modified by BMI.

Authors:  Virginia Esteve-Luque; Marta Fanlo-Maresma; Ariadna Padró-Miquel; Emili Corbella; Maite Rivas-Regaira; Xavier Pintó; Beatriz Candás-Estébanez
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

Review 2.  Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia.

Authors:  Eszter Berta; Noémi Zsíros; Miklós Bodor; István Balogh; Hajnalka Lőrincz; György Paragh; Mariann Harangi
Journal:  Genes (Basel)       Date:  2022-06-27       Impact factor: 4.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.